Journal for ImmunoTherapy of Cancer (Nov 2020)

861 Development of FPA157, an anti-CCR8 depleting antibody engineered to preferentially eliminate tumor-infiltrating T regulatory cells

  • Andrew Rankin,
  • Edwina Naik

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0861
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.